Q3 2024 saw a 17.5% year-over-year sales decline, but market conditions are improving and new products like the Refine chair and Era 2 case are driving optimism for Q4 and 2025. Margins were pressured by discounts, but strong cash flow and new partnerships support future growth.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.